• In 2014, the market grew by more than 7 percent.
• It was led by the foot and ankle device and shoulder reconstruction device markets.
• The market drivers include an aging population, the increased variety of implants and an associated increase in education of surgeons and the public.
• There has also been a shift towards arthroplasty devices and away from fusion where possible.
• Overall, the market remains strongly growing and will likely see further growth when stemless devices take to market in the United States by 2016.
More articles on devices:
FDA approves Tornier’s shoulder system, aims to improve shoulder arthroplasty — 4 things to know
Piper Jaffray assumes Integra LifeSciences coverage — 5 things to know
Zimmer sells $7.65B of senior notes for Biomet merger — 7 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
